Home » Topics » Regulatory » EMA

EMA
RSS

EMA committee recommends approval of Opdivo for advanced melanoma

April 27, 2015

Positive European opinion on methylnaltrexone bromide for opioid-induced constipation

April 27, 2015

Critical Path Institute's skeletal muscle safety markers supported by regulatory agencies

April 16, 2015

EMA approves compassionate use of OMS-721 in patients with aHUS

April 15, 2015

European orphan drug designation for Trappsol Cyclo transferred to MNE

April 9, 2015

Repros' enclomiphene eligible for new active substance status

April 8, 2015

EMA approves Vectibix for metastatic colorectal cancer expressing wild-type RAS

April 7, 2015

EMA committee recommends approval of Akynzeo

April 1, 2015

EMA committee hands down positive opinion for Lenvima in differentiated thyroid carcinoma

March 31, 2015

CHMP recommends approval of empagliflozin/metformin for type 2 diabetes

March 31, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...